Product
Menveo
Aliases
Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine
1 clinical trial
2 indications
Indication
InfectionIndication
MeningococcalClinical trial
A Single Center, Randomized, Observer-blinded, Active Comparator Phase I Study to Assess the Safety and Immunogenicity of Meningococcal (Groups A, C, W-135, X and Y) Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years OldStatus: Completed, Estimated PCD: 2023-05-10